SCHEMBL20943333

SCHEMBL20943333

O=C(CCCCCC(CCCCCC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SLC15A1 P46059 2/20 0.49
EPHX2 P34913 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
FOLH1 Q04609 2/20 0.45
CPB2 Q96IY4 1/20 0.44
SLC1A3 P43003 1/20 0.44
SLC1A1 P43005 1/20 0.44
CPA3 P15088 1/20 0.44
LMNA P02545 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CDC25B P30305 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20943329 1.00 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2
SCHEMBL22483207 0.98 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2
SCHEMBL20960093 0.94 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A
SCHEMBL20943396 0.93 MEN1 (0.55) ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A
SCHEMBL20943380 0.93 MEN1 (0.55) ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A
SCHEMBL20943382 0.90 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A
SCHEMBL3409158 0.90 MEN1 (0.52) ALDH1A1KMT2AMEN1HPGDFOLH1
SCHEMBL20943371 0.88 MMP3 (0.47) ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2
SCHEMBL8491358 0.88 ALDH1A1 (0.57) ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A
SCHEMBL4941879 0.87 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-09-14 US disclosed
EP-3476832-B1 CATIONIC LIPID EISAI R&D MAN CO LTD (JP) 2023-04-19 EP disclosed
US-11472766-B2 Lipid nanoparticle composition Suzhou Abogen Biosciences Co., Ltd. (CN) 2022-10-18 US disclosed
US-20220153686-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2022-05-19 US disclosed
CN-109311809-B Cationic lipids 卫材R&D管理有限公司 2022-04-08 CN disclosed
US-20190218180-A1 Cationic Lipid EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-07-18 US disclosed
US-20190218180-A1 Cationic Lipid EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-07-18 US disclosed
EP-3476832-A1 CATIONIC LIPID Eisai R&D Management Co., Ltd. (JP) 2019-05-01 EP disclosed
EP-3476832-A1 CATIONIC LIPID Eisai R&D Management Co., Ltd. (JP) 2019-05-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190218180-A1 Cationic Lipid NPC1L1, NPC1, LPCAT1 ALDH1A1 1462/4885MAPK1 1519/4885L3MBTL1 344/4885
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885
US-20220153686-A1 LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885
US-11472766-B2 Lipid nanoparticle composition CETP, NPC1, LCAT ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.